Cargando…

A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening

Programmed −1 ribosomal frameshifting (−1 PRF) is a mechanism that directs elongating ribosomes to shift-reading frame by 1 base in the 5′ direction that is utilized by many RNA viruses. Importantly, rates of −1 PRF are fine-tuned by viruses, including Retroviruses, Coronaviruses, Flavivriuses and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakauskaitė, Rasa, Liao, Pei-Yu, Rhodin, Michael H. J., Lee, Kelvin, Dinman, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152369/
https://www.ncbi.nlm.nih.gov/pubmed/21602263
http://dx.doi.org/10.1093/nar/gkr382
_version_ 1782209764076290048
author Rakauskaitė, Rasa
Liao, Pei-Yu
Rhodin, Michael H. J.
Lee, Kelvin
Dinman, Jonathan D.
author_facet Rakauskaitė, Rasa
Liao, Pei-Yu
Rhodin, Michael H. J.
Lee, Kelvin
Dinman, Jonathan D.
author_sort Rakauskaitė, Rasa
collection PubMed
description Programmed −1 ribosomal frameshifting (−1 PRF) is a mechanism that directs elongating ribosomes to shift-reading frame by 1 base in the 5′ direction that is utilized by many RNA viruses. Importantly, rates of −1 PRF are fine-tuned by viruses, including Retroviruses, Coronaviruses, Flavivriuses and in two endogenous viruses of the yeast Saccharomyces cerevisiae, to deliver the correct ratios of different viral proteins for efficient replication. Thus, −1 PRF presents a novel target for antiviral therapeutics. The underlying molecular mechanism of −1 PRF is conserved from yeast to mammals, enabling yeast to be used as a logical platform for high-throughput screens. Our understanding of the strengths and pitfalls of assays to monitor −1 PRF have evolved since the initial discovery of −1 PRF. These include controlling for the effects of drugs on protein expression and mRNA stability, as well as minimizing costs and the requirement for multiple processing steps. Here we describe the development of an automated yeast-based dual fluorescence assay of −1 PRF that provides a rapid, inexpensive automated pipeline to screen for compounds that alter rates of −1 PRF which will help to pave the way toward the discovery and development of novel antiviral therapeutics.
format Online
Article
Text
id pubmed-3152369
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-31523692011-08-08 A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening Rakauskaitė, Rasa Liao, Pei-Yu Rhodin, Michael H. J. Lee, Kelvin Dinman, Jonathan D. Nucleic Acids Res Methods Online Programmed −1 ribosomal frameshifting (−1 PRF) is a mechanism that directs elongating ribosomes to shift-reading frame by 1 base in the 5′ direction that is utilized by many RNA viruses. Importantly, rates of −1 PRF are fine-tuned by viruses, including Retroviruses, Coronaviruses, Flavivriuses and in two endogenous viruses of the yeast Saccharomyces cerevisiae, to deliver the correct ratios of different viral proteins for efficient replication. Thus, −1 PRF presents a novel target for antiviral therapeutics. The underlying molecular mechanism of −1 PRF is conserved from yeast to mammals, enabling yeast to be used as a logical platform for high-throughput screens. Our understanding of the strengths and pitfalls of assays to monitor −1 PRF have evolved since the initial discovery of −1 PRF. These include controlling for the effects of drugs on protein expression and mRNA stability, as well as minimizing costs and the requirement for multiple processing steps. Here we describe the development of an automated yeast-based dual fluorescence assay of −1 PRF that provides a rapid, inexpensive automated pipeline to screen for compounds that alter rates of −1 PRF which will help to pave the way toward the discovery and development of novel antiviral therapeutics. Oxford University Press 2011-08 2011-05-20 /pmc/articles/PMC3152369/ /pubmed/21602263 http://dx.doi.org/10.1093/nar/gkr382 Text en © The Author(s) 2011. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methods Online
Rakauskaitė, Rasa
Liao, Pei-Yu
Rhodin, Michael H. J.
Lee, Kelvin
Dinman, Jonathan D.
A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening
title A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening
title_full A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening
title_fullStr A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening
title_full_unstemmed A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening
title_short A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening
title_sort rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening
topic Methods Online
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152369/
https://www.ncbi.nlm.nih.gov/pubmed/21602263
http://dx.doi.org/10.1093/nar/gkr382
work_keys_str_mv AT rakauskaiterasa arapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening
AT liaopeiyu arapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening
AT rhodinmichaelhj arapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening
AT leekelvin arapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening
AT dinmanjonathand arapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening
AT rakauskaiterasa rapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening
AT liaopeiyu rapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening
AT rhodinmichaelhj rapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening
AT leekelvin rapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening
AT dinmanjonathand rapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening